Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70377-080

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70377-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container-label-10mg.jpg (Container Label 10mg)

Atorvastatin Calcium 10 mg film-coated tablets label from Biocon Pharma Inc. The label includes NDC 70377-077-11, states the product is prescription-only, and contains 90 tablets. It provides storage instructions, dosage information, manufacturing details for Biocon Pharma Inc. and Recipharm Pharmaservices Pvt Ltd, India, and includes a barcode. The label specifies the tablet strength as 10 mg equivalent atorvastatin calcium USP.*

FDA Label Image

Container-label-20mg.jpg (Container Label 20mg)

Label for Atorvastatin Calcium Tablets USP 20 mg, film-coated tablets, oral use, in a package of 90 tablets. The label shows the NDC number 70377-078-11, the Biocon logo, and storage instructions. It notes the product is Rx only and provides manufacturer details for Biocon Pharma Inc. and Recipharm Pharmaservices Pvt. Ltd.*

FDA Label Image

Container-label-40mg.jpg (Container Label 40mg)

Atorvastatin Calcium 40 mg film-coated tablets label by Biocon Pharma Inc. The label includes NDC 70377-079-11 and states the package contains 90 tablets. Storage instructions specify 20°C to 25°C (68°F to 77°F). It mentions the product is child-resistant and for oral use, with dosage and use information referring to the package insert. Manufacturer details for Biocon Pharma Inc. and Reipharm Pharmaservices Pvt. Ltd. are present.*

FDA Label Image

Container-label-80mg.jpg (Container Label 80mg)

Label for Atorvastatin Calcium Tablets, USP 80 mg film-coated tablets. The label states the container holds 90 tablets and is marketed by Biocon Pharma Inc. It includes storage instructions, dosage directions referring to the package insert, and child-resistant packaging information. The label also shows NDC 70377-080-11 and manufacturing details for Recipharm Pharmaservices Pvt. Ltd., Bengaluru, India.*

FDA Label Image

Figure 1.jpg (Figure1)

A line chart showing cumulative incidence percentages over 3.5 years comparing Atorvastatin to placebo. The graph displays two lines: a solid line for Atorvastatin and a dashed line for placebo, with the placebo line consistently higher than the Atorvastatin line over time. Hazard ratio (HR) and p-value are also noted below the x-axis.*

FDA Label Image

Figure 2.jpg (Figure2)

A cumulative hazard plot comparing Atorvastatin and placebo over a follow-up period of up to five years. The graph shows cumulative hazard percentage on the y-axis and time to first primary endpoint in years on the x-axis, with separate curves for Atorvastatin (solid line) and placebo (dashed line). The hazard ratio (HR), confidence interval, and p-value are noted on the chart.*

FDA Label Image

Figure 3.jpg (Figure3)

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over a 5-year period for Atorvastatin 10 mg and 80 mg oral tablets. The x-axis shows time in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) with confidence interval and p-value.*

FDA Label Image

Chemical Structure (Chemical Structure)

Chemical structure diagram of atorvastatin calcium showing the molecular arrangement including calcium ions (Ca2+) and hydration with 3 molecules of water (3H2O). The structure features a fluorophenyl group and hydroxy groups relevant to the active ingredient atorvastatin calcium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.